Global inhalation anesthesia market to reach USD 1473.5 million by 2026.

Global inhalation anesthesia market Size study, by product (sevoflurane, desflurane and isoflurane and others) end user (Hospital, ASC and others) and Regional Forecasts 2019-2026.
Product Code:  HALDAT_27930784
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.	Inhalation Anaesthesia Market, by Type, 2016-2026 (USD Billion)
1.3.2.	Inhalation Anaesthesia Market, by End-user, 2016-2026 (USD Billion)
1.3.3.	Inhalation Anaesthesia Market, by Region, 2016-2026 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Inhalation Anaesthesia Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Inhalation Anaesthesia Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Inhalation Anaesthesia Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Key Buying Criteria (On Demand)
4.4.	Regulatory Framework (On Demand)
4.5.	Investment Vs Adoption Scenario (On Demand)
4.6.	Analyst Recommendation & Conclusion
Chapter 5.	Global Inhalation Anaesthesia Market, By Type
5.1.	Market Snapshot 
5.1.	Market Performance - Potential Model
5.2.	Global Inhalation anaesthesia Market, Sub Segment Analysis
5.2.1.	     Desflurane 
5.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.2.2.	     Isoflurane  
5.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.2.3.	 Sevoflurane
5.2.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.2.4.	Others 
5.2.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.4.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6.	Global Inhalation Anaesthesia Market, By End-user 
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Global Inhalation anaesthesia Market, Sub Segment Analysis
6.3.1.	      Hospitals 
6.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.	  ASCs
6.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.3.	Others 
6.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 
Chapter 7.	Global Inhalation Anaesthesia Market, by Regional Analysis
7.1.	Inhalation anaesthesia Market, Regional Market Snapshot (2016-2026)
7.2.	North America Inhalation anaesthesia Market Snapshot
7.2.1.	U.S.
7.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.2.	 Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.	Canada
7.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.	Europe Inhalation anaesthesia Market Snapshot
7.3.1.	U.K. 
7.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)

7.3.2.	Germany 
7.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.	Rest of Europe
7.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.	Asia Inhalation anaesthesia Market Snapshot
7.4.1.	China 
7.4.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.	India 
7.4.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.	Japan
7.4.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.	Rest of Asia Pacific
7.4.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)

7.5.	Latin America Inhalation anaesthesia Market Snapshot
7.5.1.	Brazil 
7.5.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)

7.5.2.	Mexico 
7.5.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.	Rest of The World 
7.6.1.	Middle East and Africa
7.6.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.3.	 End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8.	Competitive Intelligence
8.1.	Company Market Share (Subject to Data Availability)
8.2.	Top Market Strategies
8.3.	Company Profiles
8.3.1.	  AbbVie, Inc. 
8.3.1.1.	Overview
8.3.1.2.	Financial (Subject to Data Availability)
8.3.1.3.	Product Summary
8.3.1.4.	Recent Developments
8.3.2.	  Baxter 
8.3.3.	 Lunan Pharmaceuticals Co Ltd  
8.3.4.	  Piramal Healthcare 
8.3.5.	  Halocarbon Products Corporation 
8.3.6.	 Jiangsu Hengrui Medicine Co. Ltd.
8.3.7.	 Fresenius Kabi AG 
8.3.8.	 Halocarbon Products Corporation    
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.1.6.	Research Assumption

Global inhalation anesthesia market is valued approximately USD 1174.09 million in 2018 and is anticipated to grow with a healthy growth rate of more than 2.9% over the forecast period 2019-2026. Better patient outcomes resulting from inhalation anesthesia as compared to intravenous variants along with the increase in number of number of surgeries are the key trends that are responsible for the wide adoption of inhalation anesthesia globally.
Major driver for the growth of global inhalation anesthesia market is the growing prevalence of chronic diseases that in turn have created the demand for surgical procedures positive. Chronic diseases are of long duration and progress slowly caused due to lifestyle choice, environment exposure, heredity and genetic vulnerability. Some of the leading chronic diseases in the world are diabetes, cancer, mental disorders, stroke, cardio vascular diseases, obesity, and arthritis. As per data released by World Health Organization (WHO), chronic diseases result in average 16 million mortality worldwide. Every year, over 12 million new cases of cancer are detected and over 7.5 million people die from it. According to World Health Organization (WHO), it is predicted that by 2030, 23.3 million people would be fatally affected by CVD, CHD and other heart diseases. Overall, death due to chronic diseases in the world is anticipated to increase from 40 million in 2016 to 52 million 2030 as per WHO. More than 80% of the deaths are caused by cancer, diabetes, chronic respiratory diseases, and cardiovascular disease. Inhalation anesthesia are extensively used while performing surgical procedures, hence with the growing prevalence of chronic diseases, the demand for inhalation anesthesia would grow substantially. Further, growing geriatric population, escalating number of emergency cases and accident and reduction in the recovery time subsequently surgery with the use of inhalation anesthesia are the other major factors driving global inhalation anesthesia market. However, side effects associated with anesthesia and low availability of skilled anesthetics experts are the major factors that impede the growth of global inhalation anesthesia market.
On the basis of segmentation, the inhalation anesthesia market is segmented into Type and end-user. The type segment of global inhalation anesthesia market is classified into sevoflurane, desflurane and isoflurane of which sevoflurane is expected to dominate the product segment primarily due to benefits associated with sevoflurane that include low flammability, nominal respiratory and cardiovascular side effects, non-pungent odor, intrinsic stability and others. These benefits of sevoflurane have leveraged huge adoption of sevoflurane for inhalation anesthesia. The end-users segment of the global inhalation anesthesia is classified into Hospitals, ASCs and others .

The regional analysis of inhalation anesthesia market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America have occupied major share in the global inhalation anesthesia market. Major reasons for the dominance of North America are sound healthcare infrastructure in the region, coupled with growing prevalence of chronic disease, growing number of cosmetic procedures (Surgical and non-surgical) and rising healthcare expenditure. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific is witnessed owing to increasing number of hospitals, clinics in region coupled with rising geriatric population and increasing healthcare expenditure.
The leading market players include-

AbbVie, Inc.
Baxter
Lunan Pharmaceuticals Co Ltd
Piramal Healthcare
Halocarbon Products Corporation
Jiangsu Hengrui Medicine Co. Ltd.
Fresenius Kabi AG
Halocarbon Products Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Sevoflurane
Desflurane
Isoflurane
Others
By end-user:
Hospitals
ASC
Others
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
ROE
Asia Pacific
China
India
Japan
ROAPEC
LAMEA
Brazil
Mexico
ROW
Middle East & Africa

Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Inhalation Anesthesia Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…